pharma stocks

Wally Klemp, with Moleculin Biotech, Inc. (MBRX), discusses on Uptick Network their new treatment for Second-Line Leukemia Patients

Innovus Pharmaceuticals Eliminates Over $1.8M in Liabilities

Innovus Pharma Announces the Filing of the Product Licenses for Zestra, Zestra Glide, EjectDelay and Sensum+ with the Indian FDA (Directorate General of Health Services) by its Partner Khandelwal Laboratories

Innovus Pharma to Request Regulatory Guidance for Filing for its FlutiCare™ Product in Europe for the Treatment of Allergic Rhinitis

Innovus (INNV) Brings Leading Nasal Steroid from Rx to OTC

Premier Biomedical Confirms Consolidation of Debt

Uptick Network – Interview with CEO Ken Manzo With Manzo Pharmaceuticals, Inc.

Innovus Pharma Achieves Major Milestone with Securing a Manufacturing Agreement for FlutiCare™ in Anticipation of the FDA Decision

Innovus Pharma Signs Exclusive License and Distribution Agreement with BroadMed for EjectDelay®in Lebanon

Premier Biomedical Announces the Appointment of Dr. James Frincketo Chief Technical Officer Position

Innovus Pharma Joins AbbVie Inc. and Eli Lilly & Co. in the Race for the $3 Billion Testosterone Replacement Market

Innovus Pharma CEOProvides Shareholder Update and Conference Call

What an NYSE-MKT Uplisting Means for OTC Companies like Innovus Pharma (INNV)

GTX Corp Elaborates about the GPS SmartSole Product and its Positioning in the Growing IoT and Wearables Industry

Upcoming PDUFA and ANDA Approval Dates Could Catalyze Innovus Pharma (INNV) and Lipocine (LPCN)